CreakyJoints

CreakyJoints

CreakyJoints is an online community dedicated to millions of people with arthritis and their caregivers around the globe. It offers education, support, advocacy, and research focused on patient needs. All of our programs and services are completely free.

International
English
Non-profit, Online/Digital

Outlet metrics

Domain Authority
59
Ranking

Global

#249582

United States

#98466

Health/Health Conditions and Concerns

#216

Traffic sources
Monthly visitors

Articles

  • Dec 19, 2024 | creakyjoints.org | Kelsey Kloss

    Participating in a lupus clinical trial can be a valuable option if you’re living with this chronic autoimmune disease. These trials often provide access to potential new treatments that aren’t yet widely available. However, it’s understandable to have concerns, as clinical trials are sometimes surrounded by misconceptions, myths, and uncertainties. This is especially true since information on new treatments can be limited, particularly for groups like BIPOC patients.

  • Dec 19, 2024 | creakyjoints.org | Kelsey Kloss

    Participating in a lupus clinical trial may be helpful if you have exhausted other treatment options or simply want access to study medications. It can also be rewarding if you want to contribute to the body of research available for the lupus community. That said, there’s understandably quite a bit to consider when you’re preparing for a lupus clinical trial, including what your support system will look like.

  • Dec 19, 2024 | creakyjoints.org | Kelsey Kloss

    Joining a lupus clinical trial is a big decision, and one of many factors to consider is how it could impact your lupus symptoms. Living with lupus often involves trial and error with treatments and managing unpredictable symptoms. If you enter a clinical trial feeling informed, prepared, and empowered, it might offer a unique opportunity to learn more about your individual experience with lupus.

  • Dec 9, 2024 | creakyjoints.org | Shelley Fritz

    The 2024 American College of Rheumatology (ACR) Convergence highlighted exciting new research that could transform health care. From innovative therapies for lupus treatment to technologies that are reshaping rheumatoid arthritis (RA) care, we’re spotlighting the research that matters most to you.

  • Nov 25, 2024 | creakyjoints.org | Susan Jara

    At the 2024 American College of Rheumatology (ACR) Convergence, patients, clinicians, and researchers came together to discuss an innovative treatment for rheumatoid arthritis (RA): neuroimmune modulation. This therapy is a first-of-its-kind treatment for people living with moderate-to-severe RA who haven’t found relief from at least one biologic or targeted medication or can’t tolerate them.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Traffic locations